8.9 Summary
19 June 2020: any MRCA Treatment Pathway 1 and Treatment Pathway 2 information below has been retained for historical purposes only. A Single Treatment Pathway has been in effect since 12 December 2019. See section 8.1 Overview for current information.
Under the MRCA, the intention is that persons with ongoing treatment needs will be provided with a Repatriation Health Card as per Treatment Pathway 2. There are a few approaches that should be taken to ensure these arrangements work for MRCA persons.
Prior to placing a person on Treatment Pathway 2 delegates should check that:
- Any current treating Doctors accept DVA's payment arrangement for Repatriation Health Card holders; and
- Any current treatment is provided for in the MRCA Treatment Principles.
If a type of treatment is not automatically provided for by the White Repatriation Health C — ard (treatment principles) then a request for prior approval should be submitted to the Medical and Allied Health section in Primary Health Group. Requests for higher rates of payment, than provided for in the Repatriation Schedule of Fees, should also be submitted to the Medical and Allied Health section for consideration.
Delegates may also consider whether a form of treatment should be included in a rehab — ilitation program, particularly where a person is already on a rehab — ilitation program.
Only after considering all the above options should we transfer a person back to Treatment Pathway 1. However, if a person has a Gold Repatriation Health Card then it is not possible to transfer that person to Treatment Pathway 1.
Wherever practical, we should issue Repatriation Cards as soon as possible after accepting liability. For full-time serving members this is during the transition out of the ADF. For Reservists and former members this is immediately upon admission of liability and com — pletion of a Needs Assessment.
0/00/00 — Page 1
Source URL: https://clik.dva.gov.au/military-compensation-mrca-manuals-and-resources-library/policy-manual/ch-8-treatment-injuries-and-diseases/89-summary